Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells

Cancer Letters

Volumn 291, Issue 2, 2010, Pages 187-199

  Yap, Wei Ney ^a   Zaiden, Norazean ^a   Tan, Yee Ling ^b   Ngoh, Chang Piek ^c   Zhang, Xue Wu ^d   Wong, Y C ^e   Ling, M T ^f   Yap, Yee Leng ^a  

^a DAVOS LIFE SCIENCE PTE LTD   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f Translational Research Institute   (Australia)

Author keywords

Breast cancer; Chemosensatizing; Docetaxel; Id 1; Tocopherol; Tocotrienol; Vitamin E

Indexed keywords

3 AMINOPROPIONITRILE; ALPHA TOCOPHEROL; CASPASE; DNA; DOCETAXEL; FOCAL ADHESION KINASE; GAMMA TOCOTRIENOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 1; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEIN TYROSINE KINASE; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE G1 PHASE; CELL PROTECTION; CELL STRAIN MCF 7; CHEMOSENSITIZATION; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

ANDROGENS; BREAST NEOPLASMS; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CHROMANS; COLLAGEN; DNA FRAGMENTATION; DOWN-REGULATION; DRUG COMBINATIONS; ESTROGENS; FEMALE; HUMANS; IN SITU NICK-END LABELING; INHIBITOR OF DIFFERENTIATION PROTEIN 1; LAMININ; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR CELLS, CULTURED; VITAMIN E;

EID: 77950300003     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.10.012     Document Type: Article

References (64)

1. Ries L.A.G., et al. SEER Cancer Statistics Review, 1975-2004 (2006), National Cancer Institute, Bethesda, MD
2. Yde C.W., et al. The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells. Anticancer Drugs 20 (2009) 723-735
3. Leonessa F., et al. Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies. Cancer Res. 54 (1994) 441-447
4. Smith I.C., et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J. Clin. Oncol. 20 (2002) 1456-1466
5. Schiff P.B., Fant J., and Horwitz S.B. Promotion of microtubule assembly in vitro by taxol. Nature 277 (1979) 665-667
6. Ahmad N.S., et al. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin. Exp. Pharmacol. Physiol. 32 (2005) 761-770
7. Mazlan M., et al. Comparative effects of alpha-tocopherol and gamma-tocotrienol against hydrogen peroxide induced apoptosis on primary-cultured astrocytes. J. Neurol. Sci. 243 (2006) 5-12
8. Agarwal M.K., et al. Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3 (2004) 205-211
9. Eitsuka T., Nakagawa K., and Miyazawa T. Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol. Biochem. Biophys. Res. Commun. 348 (2006) 170-175
10. Kumar K.S., et al. Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant gamma-tocotrienol. Life Sci. 78 (2006) 2099-2104
11. McAnally J.A., et al. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. Exp. Biol. Med. (Maywood) 232 (2007) 523-531
12. Nesaretnam K., et al. Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice. Lipids 39 (2004) 459-467
13. Sylvester P.W., and Shah S. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Asia Pac J. Clin. Nutr. 14 (2005) 366-373
14. Sen C.K., et al. Tocotrienols: the emerging face of natural vitamin E. Vitam. Horm. 76 (2007) 203-261
15. Yap W.N., et al. Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. Br. J. Cancer 99 (2008) 1832-1841
16. Chang P.N., et al. Evidence of gamma-tocotrienol as an apoptosis-inducing, invasion-suppressing, and chemotherapy drug-sensitizing agent in human melanoma cells. Nutr. Cancer 61 (2009) 357-366
17. Samant G.V., and Sylvester P.W. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells. Cell Proliferat. 39 (2006) 563-574
18. Ahn K.S., et al. Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J. Biol. Chem. 282 (2007) 809-820
19. Ling M.T., et al. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis 26 (2005) 1668-1676
20. Jacobs L. Process for the Production of Tocotrienols (2002), Archer-Daniels-Midland Company, USA
21. Albini A., et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47 (1987) 3239-3245
22. Chu Q., et al. A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression. Carcinogenesis 27 (2006) 2180-2189
23. Nagaraja G.M., et al. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene 25 (2006) 2328-2338
24. Patel N.M., et al. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Oncogene 19 (2000) 4159-4169
25. Fong S., et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc. Natl. Acad. Sci. USA 100 (2003) 13543-13548
26. Payne S.L., et al. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res. 65 (2005) 11429-11436
27. Gautschi O., et al. Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Cancer Res. 68 (2008) 2250-2258
28. Liu Y., et al. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J. Biol. Chem. 270 (1995) 8377-8380
29. Miglietta A., et al. Conjugated linoleic acid induces apoptosis in MDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway. Cancer Lett. 234 (2006) 149-157
30. Azzam D.G., et al. ERK/MAPK regulation of the androgen responsiveness of breast cancer cells. Adv. Exp. Med. Biol. 617 (2008) 429-435
31. Mirzoeva O.K., et al. Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition. Cancer Res. 69 (2009) 565-572
32. Saha B., et al. Overexpression of E-cadherin protein in metastatic breast cancer cells in bone. Anticancer Res. 27 (2007) 3903-3908
33. Jeschke U., et al. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence. Anticancer Res. 27 (2007) 1969-1974
34. Morton R.A., et al. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res. 53 (1993) 3585-3590
35. Turashvili G., et al. Expression of E-cadherin and c-erbB-2/HER-2/neu oncoprotein in high-grade breast cancer. Cesk. Patol. 43 (2007) 87-92
36. van de Wetering M., et al. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res. 61 (2001) 278-284
37. Cano A., et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2 (2000) 76-83
38. Vesuna F., et al. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem. Biophys. Res. Commun. 367 (2008) 235-241
39. Howard E.W., et al. Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer. Clin. Cancer Res. 13 (2007) 1847-1856
40. Laux M.T., et al. Identification of a p53-dependent pathway in the induction of apoptosis of human breast cancer cells by the natural product, resveratrol. J. Altern. Complement Med. 10 (2004) 235-239
41. Qureshi A.A., et al. Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J. Nutr. 126 (1996) 389-394
42. Dawson D.A., Rinaldi A.C., and Poch G. Biochemical and toxicological evaluation of agent-cofactor reactivity as a mechanism of action for osteolathyrism. Toxicology 177 (2002) 267-284
43. Singh J., et al. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene 21 (2002) 1812-1822
44. Lin C.Q., et al. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res. 60 (2000) 1332-1340
45. Schoppmann S.F., et al. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer 104 (2003) 677-682
46. Erler J.T., et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440 (2006) 1222-1226
47. Yu W., et al. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr. Cancer 33 (1999) 26-32
48. Takahashi K., and Loo G. Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells. Biochem. Pharmacol. 67 (2004) 315-324
49. Sylvester P.W., and Shah S.J. Mechanisms mediating the antiproliferative and apoptotic effects of vitamin E in mammary cancer cells. Front. Biosci. 10 (2005) 699-709
50. Nesaretnam K., et al. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33 (1998) 461-469
51. Nesaretnam K., et al. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 30 (1995) 1139-1143
52. Nesaretnam K., Dorasamy S., and Darbre P.D. Tocotrienols inhibit growth of ZR-75-1 breast cancer cells. Int. J. Food Sci. Nutr. 51 Suppl (2000) S95-S103
53. Nesaretnam K., et al. Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Ann. NY Acad. Sci. 1031 (2004) 143-157
54. Guthrie N., et al. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J. Nutr. 127 (1997) 544S-548S
55. Elangovan S., Hsieh T.C., and Wu J.M. Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product. Anticancer Res. 28 (2008) 2641-2647
56. Sun W., et al. Gamma-tocotrienol-induced apoptosis in human gastric cancer SGC-7901 cells is associated with a suppression in mitogen-activated protein kinase signalling. Br. J. Nutr. 99 (2008) 1247-1254
57. He L., et al. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J. Nutr. 127 (1997) 668-674
58. Wada S., et al. Tumor suppressive effects of tocotrienol in vivo and in vitro. Cancer Lett. 229 (2005) 181-191
59. Qureshi A.A., et al. Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties. J. Agric. Food Chem. 48 (2000) 3130-3140
60. McIntyre B.S., et al. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc. Soc. Exp. Biol. Med. 224 (2000) 292-301
61. Zhang X., et al. Inactivation of Id-1 in prostate cancer cells: a potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway. Int. J. Cancer 118 (2006) 2072-2081
62. Kirschmann D.A., et al. A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 62 (2002) 4478-4483
63. Khanna S., et al. Delivery of orally supplemented alpha-tocotrienol to vital organs of rats and tocopherol-transport protein deficient mice. Free Radic. Biol. Med. 39 (2005) 1310-1319
64. Patel V., et al. Natural vitamin E alpha-tocotrienol: retention in vital organs in response to long-term oral supplementation and withdrawal. Free Radic. Res. 40 (2006) 763-771